Imaging-defined radionecrosis following stereotactic radiosurgery in the setting of immune checkpoint inhibitors - a cause for alarm or a harbinger of enhanced anti-tumor immunity?

Manmeet Ahluwalia, Miami Cancer Institute

Abstract